60万元保障托起“黏宝宝”新生 “深圳惠民保”破解罕见病用药困局

Group 1 - The article highlights the significant impact of the "Shenzhen Huimin Insurance" on families with rare diseases, particularly in providing financial support for treatment [1][2] - Yang Xiaobao, a one-year-old diagnosed with mucopolysaccharidosis, benefited from the insurance, which covers 70% of the treatment costs, alleviating the family's financial burden [2][3] - As of May 2025, "Shenzhen Huimin Insurance" has reimbursed approximately 270,000 yuan for Yang Xiaobao's treatment, showcasing its effectiveness in supporting rare disease patients [2][3] Group 2 - The insurance plan has expanded its coverage to include nine rare diseases and ten high-value self-paid medications for the 2025 fiscal year, increasing the annual reimbursement limit to 600,000 yuan [3] - "Shenzhen Huimin Insurance" has cumulatively compensated over 20 million yuan for self-paid medication costs, benefiting 660 individuals [3] - The enrollment period for the new insurance year is from April 22 to June 30, 2025, with coverage starting from July 1, 2025 [3]